A collaborative randomised phase III trial: The timing of intervention with androgen deprivation in prostate cancer patients with a rising PSA.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

29 July, 2026

TROG to run breast cancer trial in Australia after gaining $2.86m grant

LATEST NEWS: 29 July 2026 TROG Cancer Research is

new TROG Scientific Committee Chair Elect and members
21 July, 2026

New TROG Scientific Committee Chair-Elect and members bring diverse experience

LATEST NEWS: 21 July 2026 The TROG Scientific Committee